Search Results

Flubendazole 100 mg  | Purity Not Available

TargetMol

Flubendazole is available OTC in Europe that is an anthelmintic using to treat worm infection in humans.

More Information Supplier Page

Hydroxyzine Pamoate 100 mg  | Purity Not Available

TargetMol

Hydroxyzine Pamoate (Bobsule) is a histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.

More Information Supplier Page

Hydroxyzine Pamoate 200 mg  | Purity Not Available

TargetMol

Hydroxyzine Pamoate (Bobsule) is a histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.

More Information Supplier Page

Zalcitabine 100 mg  | 98.00%

TargetMol

Zalcitabine(Dideoxycytidine;ddC; 2′, 3′-Dideoxycytidine) is a nucleoside analog reverse transcriptase inhibitor (NRTI); At low concentrations, It can potently inhibit HIV replication by binding to reverse transcriptase terminated synthesis of viral DNA chain.

More Information Supplier Page

Cepharanthine 100 mg  | 99.74%

TargetMol

Cepharanthine, a biscoclaurine alkaloid, suppresses tumor necrosis factor (TNF)-α-mediated NFκB stimulation, plasma membrane lipid peroxidation and platelet aggregation and inhibits cytokine production.

More Information Supplier Page

Z-DEVD-FMK 1 mg  | 96.19%

TargetMol

Z-DEVD-FMK is a selective, irreversible Caspase-3 inhibitor, and also exhibits effective inhibition activity on caspase-6, caspase-7, caspase-8, and caspase-10.

More Information Supplier Page

Z-DEVD-FMK 10 mg  | 96.19%

TargetMol

Z-DEVD-FMK is a selective, irreversible Caspase-3 inhibitor, and also exhibits effective inhibition activity on caspase-6, caspase-7, caspase-8, and caspase-10.

More Information Supplier Page

AZD-8055 50 mg  | 97.45%

TargetMol

AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.

More Information Supplier Page

AZD-8055 25 mg  | 97.45%

TargetMol

AZD8055 is an ATP-competitive mTOR inhibitor (IC50: 0.8 nM in MDA-MB-468 cells). It is ~1,000-fold selective for mTOR over all PI3K isoforms.

More Information Supplier Page